Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6.
about
Evaluation of a New Serotyping Assay for Detection of Anti-Hepatitis C Virus Type-Specific Antibodies in Serum SamplesSurvey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assayHepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6Comparative evaluation of two serologic typing methods for hepatitis C virusAnalysis of hepatitis C virus isolates by serotyping and genotypingSecond-generation line probe assay for hepatitis C virus genotypingSerological determination of hepatitis C virus genotype: comparison with a standardized genotyping assayGenotypic distribution of hepatitis C virus in different regions of ThailandAntigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virusIdentification of antigenic sites on three hepatitis C virus proteins using phage-displayed peptide libraries.Serodiagnosis of porcine reproductive and respiratory syndrome virus infection with the use of glycoprotein 5 antigens.Serological determination of hepatitis C virus subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a recombinant immunoblot assay.A serotyping assay for hepatitis C virus in Southeast Asia.Viral hepatitis a to e in South mediterranean countriesSpontaneous elimination of hepatitis C virus infection: a retrospective study on demographic, clinical, and serological correlatesOncogenic potential of hepatitis C virus proteinsPeginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response.Human Leukocyte Antigen Class II Alleles Are Associated with Hepatitis C Virus Natural Susceptibility in the Chinese Population.Mix-infections with different genotypes of HCV and with HCV plus other hepatitis viruses in patients with hepatitis C in ChinaSASLT practice guidelines: management of hepatitis C virus infection.Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.Discrepancy between Hepatitis C Virus Genotypes and NS4-Based Serotypes: Association with Their Subgenomic Sequences.An overview about hepatitis C: a devastating virus.A novel antigen detection immunoassay for field diagnosis of hepatitis C virus infection.Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene).Molecular Assay and Genotyping of Hepatitis C Virus among Infected Egyptian and Saudi Arabian Patients.Genetic variations in vitamin D receptor were associated with the outcomes of hepatitis C virus infection among Chinese population.Single nucleotide polymorphisms of toll-like receptor 7 in hepatitis C virus infection patients from a high-risk chinese population.Study of the hepatitis C virus in the republic of macedonia.Association of genetic variants in estrogen receptor α with HCV infection susceptibility and viral clearance in a high-risk Chinese population.Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct Group.Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong.Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group.Evaluation of two simplified methods for genotyping hepatitis C virus.Serotyping and genotyping of hepatitis C virus (HCV) strains in chronic HCV infection. Commission Hepatologie du CREGG. Club de Reflexion des Cabinets de Groupes en GastroEnterologie.Large-scale analysis of hepatitis C virus serological typing assay: effectiveness and limits.Relation between reactivity to the NS-4 region peptides of hepatitis C virus (HCV) and clinical features among patients infected with HCV genotype 1b.Serological differentiation between HCV subtypes 1a and 1b by a recombinant immunoblot assay.Prevalence of antibodies against hepatitis C virus among blood donors in Lebanon, 1997-2000.Identification of an immunodominant sequential epitope in glycoprotein G of herpes simplex virus type 2 that is useful for serotype-specific diagnosis.
P2860
Q27473495-D42DA29E-EF43-4F29-9E07-6B70A169FBFCQ27485682-F12DE363-DAE5-46A1-9681-54858FF9E996Q27485684-6D6DC6AA-F293-4B61-964F-8ABDC19A7880Q27485687-1BA81C97-D6D2-4B54-8001-D93D210C8821Q27485704-798AFE86-6E8D-4FFD-8944-AC01395A7936Q27485722-F3BF2732-FFA7-4309-8D23-6AC5F4B84796Q27485780-E822097E-C2D4-4B70-8D1B-F490491E033CQ27485781-A3F65DF7-710E-42FF-B9B7-58F28CC145EDQ27485791-6A073DE0-A085-468B-96A5-32F7753B2BDFQ32018706-DBE544EA-7A73-4206-A3EE-AD9D0066D01CQ33960664-84251C8A-8AD0-4E8D-A846-D3027E6D7583Q33961998-367B9290-89DE-462A-99CF-4230137FFD72Q33997485-8243491F-E0DA-41AC-816A-919A102A07E1Q34549186-004AF10D-6AA0-48C4-9115-AE8E550CDBBBQ34604833-6BC55B8A-629F-4D1C-B301-C49C9D548910Q35261292-B3BD326D-36AB-4E95-9AF9-3B08A454BDB8Q35597434-3EF24AA1-1FE6-4D7C-A137-C82770758D76Q36088382-A435A1F6-5489-4B7F-A4EF-9551FE68F45FQ36178576-0429D7F0-C74C-42A9-A94B-A6CCC49C0C23Q37019765-7C048777-BF41-4E96-8395-AACB84FD0F45Q37527686-867E09A1-44D4-4015-8E53-EAD4951B8993Q37631645-312298EE-0953-41C0-908E-5C767A86CEB9Q37719516-3CCCB6CF-094F-4950-92DF-80A40586FEAFQ38883263-DE52F308-5020-4B02-8C73-D23982C6A9FEQ39464514-A794DBDA-DC45-4F08-8109-1C543C6E4544Q40381500-EEA82159-C447-4334-A5A4-0584CEB16CBDQ40962211-A708E340-C34D-4BDE-A2F5-F5926C751AEDQ41740477-B2434E5B-B37A-48E3-B3C2-8A7DB7B2F9FBQ41926938-8D35EA77-F8CA-413A-BDC4-D19944F56C6AQ42244898-1F93956C-6221-4344-B505-AC857D7307A5Q42979805-9D78D347-4CDB-4A59-BCBF-8EE4D7FA0C10Q42980131-90C0E22C-80C9-4ECA-8C39-0F3A59317B1EQ42982311-28BC482B-EC3A-43DD-B9C4-B4D0160898F8Q42982618-A90D22B7-1065-41B9-BA55-8996EA0BD205Q42984289-3DD4D5B5-2B4D-4463-8C54-3165300A54F7Q42987915-79A00E50-0FDC-4267-8616-A3B6A9C49B3CQ42988498-B25D2D66-704A-4191-9223-DCB9A3A49627Q42988886-DD814E93-BCD6-4AE6-B3CD-F8A3988FB0F0Q43795768-F65ECBA9-AE55-48C8-A172-F7C9F5B5A58AQ45754335-5C7BF2E6-88B5-4631-95BE-AC5923EF4CF7
P2860
Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Use of NS-4 peptides to identi ...... genotypes 1, 2, 3, 4, 5 and 6.
@en
Use of NS-4 peptides to identi ...... genotypes 1, 2, 3, 4, 5 and 6.
@nl
type
label
Use of NS-4 peptides to identi ...... genotypes 1, 2, 3, 4, 5 and 6.
@en
Use of NS-4 peptides to identi ...... genotypes 1, 2, 3, 4, 5 and 6.
@nl
prefLabel
Use of NS-4 peptides to identi ...... genotypes 1, 2, 3, 4, 5 and 6.
@en
Use of NS-4 peptides to identi ...... genotypes 1, 2, 3, 4, 5 and 6.
@nl
P2093
P1476
Use of NS-4 peptides to identi ...... genotypes 1, 2, 3, 4, 5 and 6.
@en
P2093
Bhattacherjee V
Conradie J
El-Zayadi AR
Prescott LE
P304
P356
10.1099/0022-1317-76-7-1737
P407
P478
76 ( Pt 7)
P577
1995-07-01T00:00:00Z